Global Patient Safety Oncology TA Intern

Job Description

Global Patient Safety, Oncology TA Intern Overview  

Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world-class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for AbbVie Interns. 

The Global Patient Safety, Oncology Therapeutic Area (TA) Intern will spend your summer engaged with energetic colleagues and inspirational leaders, gaining world-class experience within one of the most dynamic organizations in the pharmaceutical industry. The intern will support the enhancement of clinical safety insights by leveraging reverse translatability to improve non-clinical capabilities (e.g. complex in vitro models (CIVM) or new approach methodologies (NAMs). Additionally, the intern will learn GPS processes and deliverables relevant to clinical development and patient safety. 

The Global Patient Safety (GPS) organization works collaboratively and strategically with colleagues across the product lifecycle to identify, evaluate, understand, and communicate the safety profile of AbbVie products to protect patients worldwide. The team plays a critical role in evaluating safety data relevant to AbbVie for both pharmaceutical and medical device products.  

The team is a high-profile and high-impact group of physicians and other health care professionals who work in close collaboration with a broad range of cross-functional colleagues. The team works collaboratively to provide product data analysis, signal monitoring, and product insights so that together as a team, the Product Safety Team (PST) can implement appropriate actions to ensure patient safety. 

As a member of the team, you are at the forefront of working with leaders to identify critical priorities and drive high-value projects that make an impact on the safety of our patients. 

Key Responsibilities Include: 

• Collaborate with PST Leads and Preclinical Safety colleagues to identify gaps in current complex in vitro models (CIVM) and new approach methodologies (NAMs) capabilities as they relate to ongoing and potential clinical safety challenges. 

• Partner with teams across Discovery, Development Biological Sciences, and Genomics, as well as external collaborators when appropriate, to enhance CIVM/NAMs and improve their utility in addressing clinical safety questions. 

• Leverage reverse translatability to inform the development and refinement of non-clinical models based on clinical safety insights. 

• Assist in the effective utilization and organization of data related to model capabilities and enhancements. 

• Contribute to the overall goals of bridging gaps between non-clinical and clinical safety, helping to inform AbbVie’s R&D pipeline and clinical safety decision-making. 

• Prepare summaries or presentations of findings and recommendations for internal stakeholders, demonstrating progress and impact on model capabilities. 

Qualifications

Minimum Qualifications  

• Currently enrolled in university, pursuing a PhD in biology, chemistry or related scientific discipline, or a programming or computational skill that is related to a scientific discipline, or other related degree. 

• Must be enrolled in university for at least one semester following the internship.  

Preferred Qualifications 

• Expected graduation date between December 2026 – June 2027. 

Benefits and Amenities  

• Competitive pay  

• Relocation support for eligible students 

• Opportunities for professional development and mentorship 

• Access to dynamic project experiences within a world-class pharmaceutical organization